Figure 2.

XendoU is required for calcium-mediated RNA degradation in vitro. (A) Recombinant wild-type XendoU was incubated with increasing concentrations of CaCl2, MgCl2, MnCl2, and total RNA from egg extract. RNA was visualized on a denaturing acrylamide gel stained with SYBR Green II. (B) Recombinant H162A and K224A were incubated with metal and RNA and visualized as in A. A very faint band (arrow) appears in the presence of calcium and K224A. (C) XendoU or mock-depleted (IgG) cytosol was incubated with 1 mM CaCl2. Recombinant wild-type XendoU (rXU) was added to XendoU-depleted, mock-depleted (IgG), or undepleted cytosol and analyzed as in A. (D) Western blot of XendoU demonstrating the antibody-mediated depletion in CSF extract as compared with undepleted (CSF) or mock-depleted (IgG) extracts. (E) Cytosol or cytosol mixed with light membranes were incubated with increasing concentrations of CaCl2, and RNA was visualized as in A.

or Create an Account

Close Modal
Close Modal